Azaloxan

Azaloxan
Systematic (IUPAC) name

1-(1-{2-[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]ethyl}piperidin-4-yl)imidazolidin-2-one
Clinical data
Identifiers
CAS Registry Number	72822-56-1^N 86116-60-1 (fumarate)
ATC code	None
PubChem	CID 6328465
ChemSpider	4886586^Y
UNII	0O653FA999^Y
ChEMBL	CHEMBL2104648^N
Chemical data
Formula	C₁₈H₂₅N₃O₃
Molecular mass	331.41 g/mol
SMILES O=C1NCCN1C2CCN(CC2)CC[C@@H]3Oc4c(OC3)cccc4
InChI InChI=1S/C18H25N3O3/c22-18-19-8-12-21(18)14-5-9-20(10-6-14)11-7-15-13-23-16-3-1-2-4-17(16)24-15/h1-4,14-15H,5-13H2,(H,19,22)/t15-/m0/s1 ^Y Key:CDFTVVPIMLXJRX-HNNXBMFYSA-N ^Y
N (what is this?) (verify)

Azaloxan (CGS-7135A) is a drug which was patented as an antidepressant by Ciba-Geigy in the early 1980s, but was never marketed.^[1]

Synthesis

Azaloxan synthesis: Ciba-Geigy, Charles F. Huebner; U.S. Patent 4,329,348 (1982).

Allyl cyanide is starting material, and catechol.

See also

References

↑ David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.

Antidepressants (N06A)

Specific reuptake inhibitors and/or receptor modulators

SSRIs	Citalopram Escitalopram Fluoxetine^# Fluvoxamine Indalpine^‡ Paroxetine Sertraline Zimelidine^‡

SNRIs	Desvenlafaxine Duloxetine Levomilnacipran Milnacipran Tofenacin Venlafaxine

NRIs	Reboxetine Viloxazine

NDRIs	Amineptine^‡ Nomifensine^‡

SARIs	Etoperidone Nefazodone^‡ Trazodone

SMSs	Vilazodone Vortioxetine

Others	Agomelatine Amisulpride Buprenorphine Bupropion Etryptamine^‡ Ketamine Lurasidone Medifoxamine^‡ Metryptamine^‡ Oxaflozane^‡ Tandospirone Teniloxazine Tianeptine

Tricyclic antidepressants

TCAs	Amineptine^‡ Amitriptyline^# Amitriptylinoxide Butriptyline^‡ Clomipramine^# Demexiptiline^‡ Desipramine Dibenzepin Dimetacrine^‡ Dosulepin Doxepin Imipramine Imipraminoxide^‡ Iprindole^‡ Lofepramine Melitracen Metapramine^‡ Nitroxazepine Nortriptyline Noxiptiline Opipramol Pipofezine Propizepine^‡ Protriptyline Quinupramine^‡ Tianeptine Trimipramine

TeCAs	Amoxapine Maprotiline Mianserin Mirtazapine Setiptiline

Others	Tiazesim

Monoamine oxidase inhibitors

Non-selective	Irreversible: Benmoxin^‡ Iproclozide^‡ Iproniazid^‡ Isocarboxazid Mebanazine^‡ Nialamide^‡ Octamoxin^‡ Phenelzine Pheniprazine^‡ Phenoxypropazine^‡ Pivhydrazine^‡ Safrazine^‡ Tranylcypromine Reversible: Caroxazone^‡

MAO_A-selective	Reversible: Eprobemide Metralindole Minaprine^‡ Moclobemide Pirlindole Toloxatone Harmine Harmaline Harmane

MAO_B-Selective	Irreversible: Selegiline Rasagiline Ladostigil Mofegiline Lazabemide

Adjunctive therapies

Atypical antipsychotics Buspirone Lithium (lithium carbonate, lithium citrate) Thyroid hormones (triiodothyronine (T₃), thyroxine (T₄))

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Index of psychology and psychiatry

Description	Mental processes

Disorders	Mental and behavioral ADHD OCD Tourette's Mood Developmental pervasive dyslexia and specific Substance-related alcohol Emotional and behavioral Symptoms and signs eponymous Evaluation and testing

Treatment	Psychotherapy CBT Drugs depression antipsychotics anxiety dementia hypnotics and sedatives psychostimulants, ADHD and nootropics